These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 23751203)

  • 1. Cell therapy with autologous mesenchymal stem cells-how the disease process impacts clinical considerations.
    Wang J; Liao L; Wang S; Tan J
    Cytotherapy; 2013 Aug; 15(8):893-904. PubMed ID: 23751203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone marrow-derived mesenchymal stromal cells from patients with end-stage renal disease are suitable for autologous therapy.
    Reinders ME; Roemeling-van Rhijn M; Khairoun M; Lievers E; de Vries DK; Schaapherder AF; Wong SW; Zwaginga JJ; Duijs JM; van Zonneveld AJ; Hoogduijn MJ; Fibbe WE; de Fijter JW; van Kooten C; Rabelink TJ; Roelofs H
    Cytotherapy; 2013 Jun; 15(6):663-72. PubMed ID: 23419679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Comparative Study of the Therapeutic Potential of Mesenchymal Stem Cells and Limbal Epithelial Stem Cells for Ocular Surface Reconstruction.
    Holan V; Trosan P; Cejka C; Javorkova E; Zajicova A; Hermankova B; Chudickova M; Cejkova J
    Stem Cells Transl Med; 2015 Sep; 4(9):1052-63. PubMed ID: 26185258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypical and functional characteristics of in vitro expanded bone marrow mesenchymal stem cells from patients with systemic sclerosis.
    Larghero J; Farge D; Braccini A; Lecourt S; Scherberich A; Foïs E; Verrecchia F; Daikeler T; Gluckman E; Tyndall A; Bocelli-Tyndall C
    Ann Rheum Dis; 2008 Apr; 67(4):443-9. PubMed ID: 17526552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of mesenchymal stem cells derived from bone marrow of children with oncohematological diseases on proliferation and self-renewal of hematopoietic progenitor cells in vitro.
    Isaikina Y; Shman T
    Exp Oncol; 2008 Jun; 30(2):121-8. PubMed ID: 18566575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigating the efficacy of amnion-derived compared with bone marrow-derived mesenchymal stromal cells in equine tendon and ligament injuries.
    Lange-Consiglio A; Tassan S; Corradetti B; Meucci A; Perego R; Bizzaro D; Cremonesi F
    Cytotherapy; 2013 Aug; 15(8):1011-20. PubMed ID: 23602577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone marrow mesenchymal stromal cells (BM-MSCs) from healthy donors and auto-immune disease patients reduce the proliferation of autologous- and allogeneic-stimulated lymphocytes in vitro.
    Bocelli-Tyndall C; Bracci L; Spagnoli G; Braccini A; Bouchenaki M; Ceredig R; Pistoia V; Martin I; Tyndall A
    Rheumatology (Oxford); 2007 Mar; 46(3):403-8. PubMed ID: 16920750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved cell survival and paracrine capacity of human embryonic stem cell-derived mesenchymal stem cells promote therapeutic potential for pulmonary arterial hypertension.
    Zhang Y; Liao S; Yang M; Liang X; Poon MW; Wong CY; Wang J; Zhou Z; Cheong SK; Lee CN; Tse HF; Lian Q
    Cell Transplant; 2012; 21(10):2225-39. PubMed ID: 22776744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon-γ-dependent inhibition of B cell activation by bone marrow-derived mesenchymal stem cells in a murine model of systemic lupus erythematosus.
    Schena F; Gambini C; Gregorio A; Mosconi M; Reverberi D; Gattorno M; Casazza S; Uccelli A; Moretta L; Martini A; Traggiai E
    Arthritis Rheum; 2010 Sep; 62(9):2776-86. PubMed ID: 20496367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preferential therapy for osteoarthritis by cord blood MSCs through regulation of chondrogenic cytokines.
    Lo WC; Chen WH; Lin TC; Hwang SM; Zeng R; Hsu WC; Chiang YM; Liu MC; Williams DF; Deng WP
    Biomaterials; 2013 Jul; 34(20):4739-48. PubMed ID: 23557858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal stem cells as an immunomodulatory therapeutic strategy for autoimmune diseases.
    Ben-Ami E; Berrih-Aknin S; Miller A
    Autoimmun Rev; 2011 May; 10(7):410-5. PubMed ID: 21256250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toll-like receptors 2 and 4 mediate the capacity of mesenchymal stromal cells to support the proliferation and differentiation of CD34⁺ cells.
    Wang X; Cheng Q; Li L; Wang J; Xia L; Xu X; Sun Z
    Exp Cell Res; 2012 Feb; 318(3):196-206. PubMed ID: 22100911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative study of the biological characteristics of mesenchymal stem cells from bone marrow and peripheral blood of rats.
    Fu WL; Zhang JY; Fu X; Duan XN; Leung KK; Jia ZQ; Wang WP; Zhou CY; Yu JK
    Tissue Eng Part A; 2012 Sep; 18(17-18):1793-803. PubMed ID: 22721583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Autologous bone marrow-derived mesenchymal stem cells and peripheral blood stem cells cotransplantation in treatment of hematological malignant diseases].
    Wu T; Bai H; Wang CB; Zhang Q; Tantai LF; Wang XJ; Ou JF; Zhao Q
    Zhonghua Nei Ke Za Zhi; 2009 May; 48(5):392-5. PubMed ID: 19615157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone marrow-derived conventional, but not cloned, mesenchymal stem cells suppress lymphocyte proliferation and prevent graft-versus-host disease in rats.
    Kitazawa Y; Li XK; Xie L; Zhu P; Kimura H; Takahara S
    Cell Transplant; 2012; 21(2-3):581-90. PubMed ID: 22793067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of mesenchymal stem cells in hematopoietic stem cell transplantation: from bench to bedsides.
    Wu KH; Wu HP; Chan CK; Hwang SM; Peng CT; Chao YH
    Cell Transplant; 2013; 22(4):723-9. PubMed ID: 23068433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clonogenic potential of hematopoietic stem cells and mesenchymal stromal cells in various hematologic diseases: a pilot study.
    Kurt Yüksel M; Topçuoğlu P; Kurdal M; Ilhan O
    Cytotherapy; 2010; 12(1):38-44. PubMed ID: 19878078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of microenvironment in mesenchymal stem cell-based regeneration of intervertebral disc.
    Huang YC; Leung VY; Lu WW; Luk KD
    Spine J; 2013 Mar; 13(3):352-62. PubMed ID: 23340343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presence of osteoclast precursor cells during ex vivo expansion of bone marrow-derived mesenchymal stem cells for autologous use in cell therapy.
    Allers C; Lasala GP; Minguell JJ
    Cytotherapy; 2014 Apr; 16(4):454-9. PubMed ID: 24176545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation and cultivation of mesenchymal stem cells from iliac crest bone marrow for further cartilage defect management.
    Lubis AM; Sandhow L; Lubis VK; Noor A; Gumay F; Merlina M; Yang W; Kusnadi Y; Lorensia V; Sandra F; Susanto NH
    Acta Med Indones; 2011 Jul; 43(3):178-84. PubMed ID: 21979283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.